Carcinoid Tumors and Carcinoid Syndrome: Why Flushing and Diarrhea Together Send Oncologists to Check Serotonin

Understanding Carcinoid Tumors

A carcinoid tumor is a type of slow-growing neuroendocrine tumor that most often arises in the gastrointestinal tract (especially the appendix, small intestine, and rectum) or in the lungs. Though many carcinoid tumors remain small and asymptomatic for years, a subset produce hormones—most notably serotonin—that can lead to a distinct collection of symptoms known as carcinoid syndrome.

Key facts about carcinoid tumors:

• Often detected incidentally during imaging or endoscopy
• May remain indolent, but hormone-producing tumors can cause systemic effects
• Occur at a rate of about 2 per 100,000 people annually
• Require specialized testing and imaging for accurate diagnosis

What Is Carcinoid Syndrome?

Carcinoid syndrome refers to the set of symptoms experienced by patients whose carcinoid tumors secrete large amounts of bioactive substances (mainly serotonin) into the bloodstream, bypassing liver metabolism. This typically happens when the tumor has metastasized to the liver or originates in the lungs.

Common features of carcinoid syndrome:

• Flushing of the skin (face, neck, upper chest)
• Chronic, often watery diarrhea
• Abdominal cramping and discomfort
• Wheezing or asthma-like symptoms
• Right-sided heart valve damage in long-standing cases

Why Flushing and Diarrhea Occur Together

Flushing and diarrhea commonly occur in tandem because both are driven by excessive serotonin and other vasoactive substances released by the tumor. Here's how each symptom develops:

• Flushing
  Serotonin and kinins cause rapid dilation of blood vessels in the skin, leading to sudden warmth, redness, and sometimes a feeling of heat or mild burning. Flushing episodes may last from a few minutes to an hour and can be triggered by stress, alcohol, or certain foods.

• Diarrhea
  Serotonin acts on gut receptors to speed up intestinal transit. This results in frequent, watery stools that can lead to dehydration and electrolyte imbalances if untreated. Diarrhea in carcinoid syndrome is often severe and persistent.

Together, these two symptoms raise suspicion among oncologists and endocrinologists that a carcinoid tumor may be overproducing serotonin—prompting targeted tests.

The Role of Serotonin

Serotonin is a neurotransmitter crucial for mood regulation, but in carcinoid syndrome it becomes a culprit:

• Overproduction overwhelms the liver's ability to break it down.
• High systemic serotonin levels trigger vasodilation (flushing) and stimulate intestinal secretion/motility (diarrhea).
• Excess serotonin can also contribute to fibrosis of heart valves and bronchoconstriction over time.

Measuring serotonin metabolites, particularly 5-hydroxyindoleacetic acid (5-HIAA) in urine, helps confirm that these symptoms stem from a hormone-secreting carcinoid tumor.

Diagnostic Approach

When flushing and diarrhea present together—especially in someone without an obvious gastrointestinal cause—clinicians will often pursue the following steps:

1. Biochemical Tests

   • 24-hour urine 5-HIAA (serotonin metabolite)
   • Plasma serotonin levels
   • Chromogranin A (CgA) as a general marker of neuroendocrine activity

2. Imaging Studies

   • CT or MRI of the chest, abdomen, and pelvis to locate primary tumors
   • Somatostatin receptor scintigraphy (Octreoscan) or Ga-68 DOTATATE PET/CT to detect small or metastatic lesions

3. Endoscopy

   • Upper endoscopy or colonoscopy to visualize and biopsy gastrointestinal lesions

4. Cardiac Evaluation

   • Echocardiogram if there's suspicion of carcinoid heart disease (right-sided valvular fibrosis)

Early and accurate diagnosis allows for timely treatment, which can significantly improve symptoms and quality of life.

Treatment Strategies

Managing a carcinoid tumor with carcinoid syndrome involves controlling hormone secretion, reducing tumor burden, and treating specific symptoms:

• Somatostatin Analogs
  Octreotide or lanreotide bind somatostatin receptors on the tumor, reducing hormone release—often the first line for flushing and diarrhea control.

• Telotristat Ethyl
  Specifically blocks serotonin production and can improve diarrhea in patients already on somatostatin analogs.

• Surgical Resection
  Whenever feasible, removing the primary tumor (and metastases) can reduce hormonal output and may be curative in localized cases.

• Peptide Receptor Radionuclide Therapy (PRRT)
  Delivers targeted radiation to tumors via radiolabeled somatostatin analogs—effective for metastatic or inoperable disease.

• Liver-Directed Therapies
  Embolization or ablation techniques can shrink liver metastases, lowering hormone release.

• Symptom Management

  • Antidiarrheals (e.g., loperamide)
  • Control of flushing triggers (dietary adjustments, stress reduction)
  • Heart valve surgery in advanced carcinoid heart disease

Living with Carcinoid Syndrome

A diagnosis of a hormonally active carcinoid tumor can feel overwhelming, but many patients achieve good symptom control and maintain quality of life. Key tips include:

• Keep a symptom diary to track flushing and diarrhea triggers.
• Stay hydrated and monitor electrolytes if chronic diarrhea is an issue.
• Work closely with a multidisciplinary team—oncology, endocrinology, cardiology, and gastroenterology.
• Be alert for new or worsening symptoms, such as difficulty breathing, persistent abdominal pain, or signs of heart failure.

When to Consider a Symptom Check

If you've experienced unexplained episodes of flushing and diarrhea—particularly if they occur together—it may be time to dig deeper. Before your doctor's appointment, you can use a free AI-powered Carcinoid Tumors symptom checker to evaluate your symptoms and help you better communicate your concerns with your healthcare provider.

Key Takeaways

• Carcinoid tumors can secrete serotonin, causing the dual symptoms of flushing and diarrhea known as carcinoid syndrome.
• Excess serotonin's effects on blood vessels and the gut explain why these symptoms often appear together.
• Diagnosis combines biochemical testing (urine 5-HIAA, plasma serotonin) with advanced imaging and targeted endoscopy.
• Treatments range from somatostatin analogs and telotristat to surgery, PRRT, and liver-directed therapies.
• Close monitoring and a team-based approach help manage long-term risks like carcinoid heart disease.

Always remember: any combination of persistent flushing and diarrhea should prompt a conversation with your healthcare provider. Speak to a doctor about your symptoms, especially if they're severe, increasing in frequency, or interfering with daily life. Early evaluation and treatment can make a significant difference in outcomes.